Inventor · disambiguated record
Daniel Simon Peeper
Also filed as: PEEPER DANIEL · PEEPER DANIEL SIMON
2 granted patents·9 pending applications·0 citations·filing 2012–2022
25Inventor score
Files withGENMAB AS7PEEPER DANIEL SIMON1STICHTING HET NEDERLANDS KANKER INST1STICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS1Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis1
Top patents by PatentIndex Score
11 records- 0175US2023321261A1Axl-specific antibody-drug conjugates for cancer treatmentGENMAB AS·Filed 2022·Application pending·0 cites
- 0265US2020397913A1Axl-specific antibody-drug conjugates for cancer treatmentGENMAB AS·Filed 2020·Application pending·0 cites
- 0362US2019022243A1Axl-specific antibody-drug conjugates for cancer treatmentGENMAB AS·Filed 2017·Application pending·0 cites
- 0460US2018326084A1Axl-specific antibody-drug conjugates for cancer treatmentGENMAB AS·Filed 2016·Application pending·0 cites
- 0553US2022133721A1Method for treating cancerGENMAB AS·Filed 2021·Application pending·0 cites
- 0647US2021070869A1Axl-specific antibodies for cancer treatmentGENMAB AS·Filed 2019·Application pending·0 cites
- 0747US2022273809A1Axl antibody-drug conjugates for use in treating cancerGENMAB AS·Filed 2020·Application pending·0 cites
- 0846US11629179B2TWEAK-receptor agonists for use in combination with immunotherapy of a cancerSTICHTING HET NEDERLANDS KANKER INST ANTONI VAN LEEUWENHOEK ZIEKENHUIS·Filed 2019·Granted Apr 18, 2023·0 cites·20 claims
- 0944US9629851B2ROCK in combination with MAPK pathwayStichting Het Nederlands Kanker Instituut—Antoni van Leeuwenhoek Ziekenhuis·Filed 2014·Granted Apr 25, 2017·0 cites·15 claims
- 1032US2017027940A1Method for treating cancerSTICHTING HET NEDERLANDS KANKER INST·Filed 2015·Application pending·0 cites
- 1119US2012225076A1Fra-1 target genes as drug targets for treating cancerPEEPER DANIEL SIMON·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Simon Peeper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →